Gambogic Acid Induces Pyroptosis of Colorectal Cancer Cells through the GSDME-Dependent Pathway and Elicits an Antitumor Immune Response

• Published in: Cancers 2022-11, Vol.14 (22), p.5505
• Main Authors: Xu, Hanjie, Zhang, Danya, Wei, Rui, Zhou, Ying, Dai, Geyang, Li, Jie, Sun, Yue, Li, Fei, Xi, Ling
• Format: Article
• Language: English
• Subjects: Antibodies; Antitumor activity; Apoptosis; Autophagy; Cancer; Cancer therapies; Care and treatment; Caspase-3; CD3 antigen; CD44 antigen; CD8 antigen; Cell cycle; Cell death; Chemotherapy; Colorectal cancer; Colorectal carcinoma; Cytotoxicity; Dendritic cells; Effector cells; Experiments; Genetic aspects; Health aspects; Immune response; Immunological memory; L-selectin; Light microscopy; Lymphocytes T; Membranes; Memory cells; Physical characteristics; siRNA; Traditional Chinese medicine; Transmission electron microscopy; Tumors
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers14225505

Pyroptosis is a recently identified form of programmed cell death (PCD) that exerts a vital influence on the antitumor immune response. GA, a xanthone structure isolated from gamboge resin, is a naturally occurring bioactive ingredient with several anticancer activities, such as activities that affect cell cycle arrest, apoptosis, and autophagy. Here, we found that GA decreased the viability of the CRC cell lines, HCT116 and CT26, in a dose- and time-dependent manner, and multiple pores and large bubbles in the membranes, which are morphological characteristics of pyroptosis, were observed by light microscopy and transmission electron microscopy (TEM). Furthermore, the cleavage of gasdermin E (GSDME) was observed after exposure to GA, along with concomitant activation of caspase-3. Additionally, GSDME-dependent pyroptosis triggered by GA could be attenuated by siRNA-mediated knockdown of GSDME and treatment with the caspase-3 inhibitor. Moreover, we found that GA induced pyroptosis and significantly inhibited tumor growth in CT26 tumor-bearing mice. Strikingly, significantly increased proportions of CD3 T cells, cytotoxic T lymphocytes (CTLs), and dendritic cells (DCs) were observed in the tumor microenvironment in the GA-treated groups. Moreover, significantly increased proportions of CTLs and effector memory T cells (TEM) (CD8 CD44 CD62L ) were also detected in the spleens of the GA-treated groups, suggesting that the pyroptosis-induced immune response generated a robust memory response that mediated protective immunity. In this study, we revealed a previously unrecognized mechanism by which GA induces GSDME-dependent pyroptosis and enhances the anticancer immune response. Based on this mechanism, GA is a promising antitumor drug for CRC treatment that induces caspase-3-GSDME-dependent pyroptosis. This study provides novel insight into cancer chemoimmunotherapy.